|
Takiishi T, Xiao P, Franchimont M, Gilglioni EH, Arroba EN, Gurzov EN, Bertrand MJ, Cardozo AK. Inhibition of RIPK1 kinase does not affect diabetes development: beta-Cells survive RIPK1 activation. Mol Metab. 2023 Mar;69:101681. doi: 10.1016/j.molmet.2023.101681. Epub 2023 Jan 24. PubMed PMID: 36707047; PubMed Central PMCID: PMC9932129.
AÑO: 2023; IF: 6.6
|
36707047
|
Bell KJ, Saad S, Tillett BJ, McGuire HM, Bordbar S, Yap YA, Nguyen LT, Wilkins MR, Corley S, Brodie S, Duong S, Wright CJ, Twigg S, de St Groth BF, Harrison LC, Mackay CR, Gurzov EN, Hamilton-Williams EE, Marino E. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022 Jan 19;10(1):9. doi: 10.1186/s40168-021-01193-9. PubMed PMID: 35045871; PubMed Central PMCID: PMC8772108.
AÑO: 2022; IF: 15.5
|
|
Brahma MK, Xiao P, Popa M, Negueruela J, Vandenbempt V, Demine S, Cardozo AK, Gurzov EN. Nova1 or Bim Deficiency in Pancreatic beta-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients. 2022 Sep 18;14(18):3866. doi: 10.3390/nu14183866. PubMed PMID: 36145242; PubMed Central PMCID: PMC9500891.
AÑO: 2022; IF: 5.0
|